Publications » 2017 » Patents and patent applications » Print version (formatted)

Patents and patent applications
1Stonans Ilmars; Dambrova Maija; Liepins Edgars; Kalvins Ivars; Grinberga Solveiga; Kuka Janis; Lola Daina; Loza Einars; Pugovics Osvalds; Vilskersts Reinis. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... SMT201600416, 10.01.2017.      

2Stonans Ilmars; Misane Ilga; Svalbe Baiba; Dambrova Maija; Zvejniece Liga; Kalvins Ivars; Veinbergs Grigorijs. Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures. EP3127539, 08.02.2017.      

3Stonans Ilmars; Misane Ilga; Svalbe Baiba; Dambrova Maija; Zvejniece Liga; Kalvins Ivars; Veinbergs Grigorijs; Cernobrovijs Aleksandrs; Vorona Maksims. Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures. CA2988045, 09.02.2017.      

4Stonans Ilmars; Misane Ilga; Svalbe Baiba; Dambrova Maija; Zvejniece Liga; Kalvins Ivars; Veinbergs Grigorijs; Cernobrovijs Aleksandrs; Vorona Maksims; - WIPO OMPI. Use of 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures. WO2017021881, 09.02.2017.      

5Pelss Janis; Domracheva Ilona; Zalubovskis Raivis; Jaudzems Kristaps. Derivatives of 2,6-diaza-bicyclo2.2.2.octane-3,5-ditione as potential anti cancer agents. LV15160, 20.02.2017.      

6Lebedevs Antons; Ponomarjovs Jurijs; Varaceva Larisa; Cernaks Dmitrijs; Cernobrovijs Aleksandrs. Ibrutiniba izejvielas iegusanas panemiens. WO2017039425, 09.03.2017.      

7Kalvins Ivars; Veinbergs Grigorijs; Vorona Maksims; Zvejniece Liga; Cernobrovijs Aleksandrs; Karina Ligita; Dambrova Maija. Method of preparation and use of pharmacologically active N-carbamoylmethyl-4(R)-phenyl-2-pyrroli.... HRP20090524, 10.03.2017.      

8Venskus Dite; Kalvins Ivars; Pjanova Dace; Petrovska Ramona; Auzins Jurgis. Genetically stable oncolytic RNA virus, method of manufacturing and use thereof. BR112016000874, 21.03.2017.      

9Zvejniece Liga; Dambrova Maija; Veinbergs Grigorijs; Vorona Maksims; Kalvins Ivars. Pharmaceutical composition for the prevention and treatment of diseases associated with elevated.... EP3142662, 22.03.2017.      

10Venskus Dite; Kalvins Ivars; Pjanova Dace; Petrovska Ramona; Auzins Jurgis. Genetically stable oncolytic RNA virus, method of manufacturing and use thereof. HK1219500, 07.04.2017.      

11Kinena Linda; Ozola Vita; Suna Edgars; Leitis Gundars; Jaudzems Kristaps; Jirgensons Aigars; Kanepe-Lapsa Iveta; Domracheva Ilona. Novel substituted aminoalkylazoles as malarial aspartic protease inhibitors. WO2017069601, 27.04.2017.      

12Stonans Ilmars; Dambrova Maija; Liepins Edgars; Grinberga Solveiga; Kuka Janis; Lola Daina; Loza Einars; Pugovics Osvalds; Vilskersts Reinis; Kalvins Ivars. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... PL2702033, 28.04.2017.      

13Stonans Ilmars; Dambrova Maija; Liepins Edgars; Grinberga Solveiga; Kuka Janis; Lola Daina; Loza Einars; Pugovics Osvalds; Vilskersts Reinis; Kalvins Ivars. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... HUE030415, 29.05.2017.      

14Kalvins Ivars; Stonans Ilmars; Dambrova Maija; Liepins Edgars; Cirule Helena; Misane Ilga; Makarova Elina. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium or pharmaceutically acceptable salt thereof.... ZA201600894, 31.05.2017.      

15Venskus Dite; Kalvins Ivars; Pjanova Dace; Petrovska Ramona; Auzins Jurgis. Genetically stable oncolytic RNA virus, method of manufacturing and use thereof. MD4480, 31.05.2017.      

16Lebedevs Antons; Ponomarjovs Jurijs; Varaceva Larisa; Cernaks Dmitrijs; Cernobrovijs Aleksandrs; Lavrinovics Edvards. Ibrutiniba izejvielas iegusanas panemiens. LV15201, 20.07.2017.      

17Liepins Edgars; Dambrova Maija; Makrecka-Kuka Marina; Kuka Janis; Makarova Elina; Sevostjanovs Eduards. Metode insulina rezistences diagnostikai, izmantojot acilkarnitinu koncentraciju noteiksanu asinis. LV15206, 20.07.2017.      

18Rostoka Evita; Sokolovska Jelizaveta; Sjakste Nikolajs; Sjakste Tatjana; Osina Kristine. 1,4-Dihidropiridina atvasinajums DNS parravumu noversanai cukura diabeta apstaklos. LV15181, 20.07.2017.      

19Zvejniece Liga; Dambrova Maija; Veinbergs Grigorijs; Vorona Maksims; Kalvins Ivars. Pharmaceutical composition for the prevention and treatment of diseases associated with elevated.... UA115010, 28.08.2017.      

20Jirgensons Aigars; Loza Einars; William Finn Paul; Charlton Michael; Ribas de Pouplana Lluis; Saint-Leger Adelaide. Novel N-acyl-diarylsulfonamide derivatives as aminoacyl t-RNA synthetase inhibitors. LV15257, 20.09.2017.      

21Jirgensons Aigars; Loza Einars; William Finn Paul; Charlton Michael; Ribas de Pouplana Lluis; Saint-Leger Adelaide; Drug Design Oxford. Novel N-acyl-diarylsulfonamide derivatives as aminoacyl t-RNA synthetase inhibitors. AU2016216782, 28.09.2017.      

22Jirgensons Aigars; Loza Einars; William Finn Paul; Charlton Michael; Ribas de Pouplana Lluis; Saint-Leger Adelaide. Novel N-acyl-diarylsulfonamide derivatives as aminoacyl t-RNA synthetase inhibitors. CN107257789, 17.10.2017.      

23Jirgensons Aigars; Loza Einars; William Finn Paul; Charlton Michael; Ribas de Pouplana Lluis; Saint-Leger Adelaide; Drug Design Oxford. Novel N-acyl-diarylsulfonamide derivatives as aminoacyl t-RNA synthetase inhibitors. KR20170118106, 24.10.2017.      

24Venskus Dite; Kalvins Ivars; Pjanova Dace; Petrovska Ramona; Auzins Jurgis. Genetically stable oncolytic RNA virus, method of manufacturing and use thereof. GEP201706763, 25.10.2017.      

25Kalvins Ivars; Makarova Elina; Sevostjanovs Eduards; Dambrova Maija; Pugovics Osvalds; Liepins Edgars; Grinberga Solveiga. Pharmaceutical composition for reducing trimethylamine N-oxide level. GEP6747, 10.11.2017.      

26Jirgensons Aigars; Loza Einars; William Finn Paul; Charlton Michael; Ribas de Pouplana Lluis; Saint-Leger Adelaide. Novel N-acyl-diarylsulfonamide derivatives as aminoacyl t-RNA synthetase inhibitors. EP3259250, 27.12.2017.